About
A focused biotechnology company with international ambitions
Who we are
Koblano Therapeutics is a biotechnology company developing differentiated antibody products for cancer.
Based in Copenhagen, with founders in Denmark and Canada, we combine a lean core team with an international network of scientific collaborators and specialist partners. Together, the team brings deep experience in drug development and business development, and in building, growing and leading international biotechnology companies.
Our aim is to take promising programs forward through the stages where rigorous science, sound decisions and strong partnerships make the greatest difference for patients.
How we work
Scientific rigor
We let data guide our decisions and hold our programs to the standards that partners, regulators and patients expect.
Focus
We concentrate our resources on a small number of programs with a clear path toward the clinic.
Partnership
We work closely with academic groups, companies and investors who share our ambition and our standards.
Partnering
We are open to discussions with pharmaceutical and biotechnology companies, academic institutions and investors.